SHARE CAPITAL AND OTHER EQUITY INSTRUMENTS (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2025

Dec. 31, 2024

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

SCHEDULE OF STOCK OPTION

A summary of the stock option activity under the Company’s incentive plan for the years ended December 31, 2024 and 2023 is presented below:

	Number of Shares			Weighted Average Exercise Price		Weighted Average Grant Date Fair Value		Weighted Average Remaining Contractual Term (years)		Aggregate Intrinsic Value
Outstanding at January 1, 2023		268		$	6,669.00	$	8,067.60		4.1	$	—
Granted		—			—		—				—
Forfeited		(100	)		552.60		464.40				—
Outstanding at December 31, 2023		168			10,290.60		13,899.60		3.4		—
Granted		—			—		—				—
Forfeited		(40	)		7,083.00		9,723.60				—
Outstanding at December 31, 2024		128		$	11,298.60	$	15,211.80		2.3	$	—
Exercisable at December 31, 2024		124		$	11,669.04	$	15,722.40		2.0	$	—

SCHEDULE OF STOCK-BASED COMPENSATION FOR RESTRICTED STOCK UNITS

The following table summarizes the Company’s recognition of stock-based compensation for restricted stock units for the following periods:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2025		2024		2025		2024
Stock-based compensation expense for RSUs:
General and administrative	$	96,716	$	162,042	$	291,776	$	476,513
Research and development		89,851		207,158		294,071		620,057
Total	$	186,567	$	369,200	$	585,847	$	1,096,570

The following table summarizes the Company’s recognition of stock-based compensation for restricted stock units for the following periods:

	Year ended December 31,
	2024		2023
Stock-based compensation expense for RSUs:
General and administrative	$	646,636	$	1,085,791
Research and development		829,311		908,294
Total	$	1,475,947	$	1,994,085

SCHEDULE OF WARRANTS OUTSTANDING

The following table summarizes information about shares issuable under warrants outstanding at December 31, 2024 and 2023:

	Warrant shares outstanding			Weighted average exercise price		Weighted average remaining life		Intrinsic value
Outstanding at January 1, 2023		3,619		$	10,504.80		3.6	$	5,514
Issued		12,841			246.60		—		—
Exercised		(678	)		246.60		—		—
Forfeited		(254	)		20,070.00				—
Outstanding at December 31, 2023		15,528			2,122.20		4.6		—
Issued		—			—		—		—
Expired		(4	)		28,800.00		—		—
Exercised		(10,856	)		246.60		—		—
Outstanding at December 31, 2024		4,668		$	6,440.40		2.7	$	—
Exercisable at December 31, 2024		4,668		$	6,440.40		2.7	$	—

SCHEDULE OF WARRANTS OUTSTANDING

The following table summarizes information about shares issuable under warrants outstanding at September 30, 2025:

	Warrant shares outstanding			Weighted average exercise price		Weighted average remaining life		Intrinsic value
Outstanding at December 31, 2024		4,668		$	6,440.40		2.7	$	—
Issued		742,238			13.49		—		—
Exercised		(240,611	)		9.32		—		—
Forfeited		(408	)		6,730.20		—		—
Outstanding at September 30, 2025		505,887			68.73		3.2		—
Exercisable at September 30, 2025		87,588		$	344.10		2.8	$	—

The following table summarizes information about investment options outstanding at December 31, 2024 and 2023:

	Investment options outstanding			Weighted average exercise price		Weighted average remaining life		Intrinsic value
Outstanding at January 1, 2023		5,945		$	1,427.40		5.1	$	—
Exercised		(5,556	)		246.60		—		—
Outstanding at December 31, 2023		389			1,800.00		4.1	$	—
Exercised		—			—		—		—
Outstanding at December 31, 2024		389		$	1,800.00		2.6	$	—
Exercisable at December 31, 2024		389		$	1,800.00		2.6	$	—

SCHEDULE OF BLACK SCHOLES VALUATION MODEL FOR VALUATION OF WARRANTS

The Company established the initial fair value of its equity classified Inducement Warrants at the date of issuance on December 28, 2023. The Company used a Black Scholes valuation model in order to determine their value. The key inputs into the Black Scholes valuation model for the valuation of the warrants are below:

	Roth and Inducement Warrants
	December 28, 2023
Term (years)		5.0
Stock price	$	280.80
Exercise price	$	246.60
Dividend yield		—	%
Expected volatility		92.0	%
Risk free interest rate		3.80	%
Number of warrants		12,841
Value (per share)	$	208.80

Restricted Stock Units (RSUs) [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

SCHEDULE OF RESTRICTED STOCK UNITS

The Company’s activity in restricted stock units was as follows for the nine months ended September 30, 2025:

	Number of shares			Weighted average fair value
Non-vested at December 31, 2024		3,992		$	288.96
Granted		19,564			15.24
Forfeited		—			—
Vested		(721	)		1,060.04
Non-vested at September 30, 2025		22,835		$	30.10

The Company’s activity in restricted stock units was as follows for the year ended December 31, 2024:

	Number of shares			Weighted average fair value
Non-vested at January 1, 2023		349		$	16,662.60
Granted		1,013			491.40
Forfeited		(242	)		4,629.60
Vested		(348	)		3,564.00
Non-vested at December 31, 2023		772			5,214.60
Granted		3,544			106.08
Forfeited		(154	)		516.60
Vested		(170	)		3,999.60
Non-vested at December 31, 2024		3,992		$	288.96

Restricted Stock [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

SCHEDULE OF RESTRICTED STOCK UNITS

The Company’s activity in restricted common stock was as follows for the years ended December 31, 2024:

	Number of shares			Weighted average fair value
Non-vested at January 1, 2024		—			—
Granted		1,216		$	75.60
Vested		(1,216	)	$	75.60
Non-vested at December 31, 2024		—		$	—